Literature DB >> 15542662

Separate sequences in a murine retroviral envelope protein mediate neuropathogenesis by complementary mechanisms with differing requirements for tumor necrosis factor alpha.

Karin E Peterson1, Scott Hughes, Derek E Dimcheff, Kathy Wehrly, Bruce Chesebro.   

Abstract

The innate immune response, through the induction of proinflammatory cytokines and antiviral factors, plays an important role in protecting the host from pathogens. Several components of the innate response, including tumor necrosis factor alpha (TNF-alpha), monocyte chemoattractant protein 1, interferon-inducible protein 10, and RANTES, are upregulated in the brain following neurovirulent retrovirus infection in humans and in animal models. However, it remains unclear whether this immune response is protective, pathogenic, or both. In the present study, by using TNF-alpha(-/-) mice we analyzed the contribution of TNF-alpha to neurological disease induced by four neurovirulent murine retroviruses, with three of these viruses encoding portions of the same neurovirulent envelope protein. Surprisingly, only one retrovirus (EC) required TNF-alpha for disease induction, and this virus induced less TNF-alpha expression in the brain than did the other retroviruses. Analysis of glial fibrillary acidic protein and F4/80 in EC-infected TNF-alpha(-/-) mice showed normal activation of astrocytes but not of microglia. Thus, TNF-alpha-mediated microglial activation may be important in the pathogenic process initiated by EC infection. In contrast, TNF-alpha was not required for pathogenesis of the closely related BE virus and the BE virus induced disease in TNF-alpha(-/-) mice by a different mechanism that did not require microglial activation. These results provide new insights into the multifactorial mechanisms involved in retrovirus-induced neurodegeneration and may also have analogies to other types of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542662      PMCID: PMC525006          DOI: 10.1128/JVI.78.23.13104-13112.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Microglia in diseases of the central nervous system.

Authors:  Peter T Nelson; Lorinda A Soma; Ehud Lavi
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

2.  Microarray analysis of cytokine and chemokine genes in the brains of macaques with SHIV-encephalitis.

Authors:  Yongjun Sui; Raghava Potula; David Pinson; Istvan Adany; Zhuang Li; Jason Day; Eisha Buch; Jane Segebrecht; Francois Villinger; Zhenqian Liu; Mingzhao Huang; Opendra Narayan; Shilpa Buch
Journal:  J Med Primatol       Date:  2003-08       Impact factor: 0.667

3.  Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection.

Authors:  Yoshiharu Miura; Naoko Misawa; Yuji Kawano; Hiroshi Okada; Yoshio Inagaki; Naoki Yamamoto; Mamoru Ito; Hideo Yagita; Ko Okumura; Hidehiro Mizusawa; Yoshio Koyanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

Review 4.  Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia.

Authors:  Ramendra N Saha; Kalipada Pahan
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

5.  An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.

Authors:  Kate A Scott; Robert J Moore; Caroline H Arnott; Nick East; Richard G Thompson; Bernard J Scallon; David J Shealy; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2003-05       Impact factor: 6.261

6.  Activation of endoplasmic reticulum stress signaling pathway is associated with neuronal degeneration in MoMuLV-ts1-induced spongiform encephalomyelopathy.

Authors:  Hun-Taek Kim; Kara Waters; George Stoica; Wenan Qiang; Na Liu; Virginia L Scofield; Paul K Y Wong
Journal:  Lab Invest       Date:  2004-07       Impact factor: 5.662

7.  Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia.

Authors:  Tomohisa Suzuki; Izumi Hide; Katsutoshi Ido; Shinichi Kohsaka; Kazuhide Inoue; Yoshihiro Nakata
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

8.  Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration.

Authors:  Derek E Dimcheff; Srdjan Askovic; Audrey H Baker; Cedar Johnson-Fowler; John L Portis
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genes.

Authors:  Paul Jolicoeur; Chunyan Hu; Tak W Mak; Jean-Claude Martinou; Denis G Kay
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.

Authors:  Karin E Peterson; John S Errett; Tao Wei; Derek E Dimcheff; Richard Ransohoff; William A Kuziel; Leonard Evans; Bruce Chesebro
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  9 in total

1.  Neurovirulence of polytropic murine retrovirus is influenced by two separate regions on opposite sides of the envelope protein receptor binding domain.

Authors:  Karin E Peterson; Susan Pourciau; Min Du; Rachel Lacasse; Melissa Pathmajeyan; David Poulsen; Mavis Agbandje-McKenna; Kathy Wehrly; Bruce Chesebro
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

2.  Overexpression of tumor necrosis factor alpha by a recombinant rabies virus attenuates replication in neurons and prevents lethal infection in mice.

Authors:  Milosz Faber; Michael Bette; Mirjam A R Preuss; Rojjanaporn Pulmanausahakul; Jennifer Rehnelt; Matthias J Schnell; Bernhard Dietzschold; Eberhard Weihe
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Neuropeptide Y Negatively Influences Monocyte Recruitment to the Central Nervous System during Retrovirus Infection.

Authors:  Tyson A Woods; Min Du; Aaron Carmody; Karin E Peterson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  Neuropeptide Y has a protective role during murine retrovirus-induced neurological disease.

Authors:  Min Du; Niranjan B Butchi; Tyson Woods; Timothy W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 5.  Innate immunity in the pathogenesis of polytropic retrovirus infection in the central nervous system.

Authors:  Karin E Peterson; Min Du
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  Infection of cardiomyocytes and induction of left ventricle dysfunction by neurovirulent polytropic murine retrovirus.

Authors:  Mohammed Khaleduzzaman; Joseph Francis; Meryll E Corbin; Elizabeth McIlwain; Marc Boudreaux; Min Du; Tim W Morgan; Karin E Peterson
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

7.  Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation.

Authors:  Stephanie D Lewis; Niranjan B Butchi; Mohammed Khaleduzzaman; Tim W Morgan; Min Du; Susan Pourciau; David G Baker; Shizuo Akira; Karin E Peterson
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

8.  Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression.

Authors:  Rachel A LaCasse; James F Striebel; Cynthia Favara; Lisa Kercher; Bruce Chesebro
Journal:  J Neuroimmunol       Date:  2008-04-08       Impact factor: 3.478

9.  Prion Strain Differences in Accumulation of PrPSc on Neurons and Glia Are Associated with Similar Expression Profiles of Neuroinflammatory Genes: Comparison of Three Prion Strains.

Authors:  James A Carroll; James F Striebel; Alejandra Rangel; Tyson Woods; Katie Phillips; Karin E Peterson; Brent Race; Bruce Chesebro
Journal:  PLoS Pathog       Date:  2016-04-05       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.